Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.25%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +33.48%
#5 Humanity Humanity +26.28%
#6 RedStone RedStone +22.97%
#7 Codatta Codatta +22.46%
#8 Walrus Walrus +17.94%
#9 Enso Enso +17.47%
#10 The Black Bull The Black Bull +15.54%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Rang in aandelen #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Aandeelprijs
$1.73
Laatst gesynchroniseerd: 2025-06-17
Marktkapitalisatie
$2.55M
Verandering (1 dag)
-0.29%
Verandering (1 jaar)
0.00%
Land
US
Handel Eiger BioPharmaceuticals, Inc. (EIGR)

Categorie

Healthcare
Prijs EIGR met de marktkapitalisatie van B
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
EIGR
$1.73
Marktkapitalisatie van Eiger BioPharmaceuticals, Inc.(EIGR)
Marktkapitalisatie: $2.55M
Vanaf August 2026 heeft Eiger BioPharmaceuticals, Inc. een marktkapitalisatie van $2.55M. Dit maakt Eiger BioPharmaceuticals, Inc. volgens onze gegevens het 36561st meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Eiger BioPharmaceuticals, Inc. van 2014 tot 2026
EIGR vergeleken met de top 5 populairste stocks
Prijs voor EIGR Aandeel B Marktkapitalisatie van B uitslagen
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,684,828 $2.55M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +213,613,124.72%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,034,731 $2.55M
Apple Inc. Apple Inc.
AAPL
$4.490T +175,926,341.05%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,813,303 $2.55M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +163,089,914.17%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,484,780 $2.55M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +144,045,097.36%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$1,914,807 $2.55M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +111,003,211.28%